Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200062343Phase 4Not yet recruiting
Phase 4, randomised trial of butorphanol and fentanyl in perioperative pain, Postoperative gastrointestinal dysfunction (POGD) and gynaecological conditions (2 arms), sponsored by Ningbo University Affiliated Hospital. Primary endpoint: Postoperative exhaust time. Planned start Jun 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200062343.